Mednax Inc Stock Performance

MD Stock  USD 20.53  1.01  4.69%   
On a scale of 0 to 100, Mednax holds a performance score of 6. The company secures a Beta (Market Risk) of -0.2, which conveys not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Mednax are expected to decrease at a much lower rate. During the bear market, Mednax is likely to outperform the market. Please check Mednax's downside variance, day median price, and the relationship between the treynor ratio and kurtosis , to make a quick decision on whether Mednax's current price movements will revert.

Risk-Adjusted Performance

Fair

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Mednax Inc are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of rather unfluctuating fundamental indicators, Mednax exhibited solid returns over the last few months and may actually be approaching a breakup point. ...more

Actual Historical Performance (%)

One Day Return
(0.97)
Five Day Return
(3.57)
Year To Date Return
0.19
Ten Year Return
(69.02)
All Time Return
299.16
Last Split Factor
2:1
Last Split Date
2013-12-20
1
Pediatrix Medical Group Inc Q3 2025 Earnings Call Highlights Strong EBITDA and Strategic ...
11/03/2025
2
Pediatrix Medical Group Returns to Profitability, Challenging Bearish Narratives on Margin Quality
11/05/2025
3
Disposition of 10000 shares by Linynsky Laura A of Mednax at 21.65 subject to Rule 16b-3
11/06/2025
4
Pediatrix Medical Groups Earnings Seem To Be Promising
11/10/2025
5
Evaluating Pediatrix Medical Group Valuation Following a 41 percent Share Price Rally
11/14/2025
6
Truist Financial Raises the PT on Pediatrix Medical , Keeps a Buy
11/17/2025
7
Segall Bryant Hamill LLC Sells 86,109 Shares of Pediatrix Medical Group, Inc. MD
11/24/2025
8
Disposition of 23000 shares by Mark Ordan of Mednax at 22.41 subject to Rule 16b-3
12/15/2025
9
Assessing Pediatrix Medical Groups Valuation After a 53 percent One-Year Share Price Rebound
12/19/2025
Begin Period Cash Flow73.3 M
Total Cashflows From Investing Activities-35.4 M

Mednax Relative Risk vs. Return Landscape

If you would invest  1,787  in Mednax Inc on October 29, 2025 and sell it today you would earn a total of  266.00  from holding Mednax Inc or generate 14.89% return on investment over 90 days. Mednax Inc is generating 0.2874% of daily returns and assumes 3.6634% volatility on return distribution over the 90 days horizon. Put differently, 32% of stocks are less risky than Mednax on the basis of their historical return distribution, and some 95% of all equities are expected to be superior in generating returns on investments over the next 90 days.
  Expected Return   
       Risk  
Allowing for the 90-day total investment horizon Mednax is expected to generate 4.89 times more return on investment than the market. However, the company is 4.89 times more volatile than its market benchmark. It trades about 0.08 of its potential returns per unit of risk. The Dow Jones Industrial is currently generating roughly 0.07 per unit of risk.

Mednax Target Price Odds to finish over Current Price

The tendency of Mednax Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to move above the current price in 90 days
 20.53 90 days 20.53 
about 70.38
Based on a normal probability distribution, the odds of Mednax to move above the current price in 90 days from now is about 70.38 (This Mednax Inc probability density function shows the probability of Mednax Stock to fall within a particular range of prices over 90 days) .
Allowing for the 90-day total investment horizon Mednax Inc has a beta of -0.2. This indicates as returns on the benchmark increase, returns on holding Mednax are expected to decrease at a much lower rate. During a bear market, however, Mednax Inc is likely to outperform the market. Additionally Mednax Inc has an alpha of 0.4286, implying that it can generate a 0.43 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta).
   Mednax Price Density   
       Price  

Predictive Modules for Mednax

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Mednax Inc. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Mednax's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
17.8821.4925.10
Details
Intrinsic
Valuation
LowRealHigh
16.5820.1923.80
Details
Naive
Forecast
LowNextHigh
17.1020.7124.33
Details
8 Analysts
Consensus
LowTargetHigh
20.6322.6725.16
Details

Mednax Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Mednax is not an exception. The market had few large corrections towards the Mednax's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Mednax Inc, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Mednax within the framework of very fundamental risk indicators.
α
Alpha over Dow Jones
0.43
β
Beta against Dow Jones-0.2
σ
Overall volatility
1.98
Ir
Information ratio 0.1

Mednax Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Mednax for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Mednax Inc can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Mednax Inc had very high historical volatility over the last 90 days
The company generated the yearly revenue of 2.01 B. Annual Net Loss to common stockholders was (99.07 M) with gross profit of 496.24 M.

Mednax Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Mednax Stock often depends not only on the future outlook of the current and potential Mednax's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Mednax's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding83.3 M
Cash And Short Term Investments348.5 M

Mednax Fundamentals Growth

Mednax Stock prices reflect investors' perceptions of the future prospects and financial health of Mednax, and Mednax fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Mednax Stock performance.

About Mednax Performance

By analyzing Mednax's fundamental ratios, stakeholders can gain valuable insights into Mednax's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Mednax has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Mednax has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Last ReportedProjected for Next Year
Days Of Inventory On Hand 46.47  44.15 
Return On Tangible Assets(0.13)(0.12)
Return On Capital Employed(0.05)(0.04)
Return On Assets(0.05)(0.05)
Return On Equity(0.15)(0.14)

Things to note about Mednax Inc performance evaluation

Checking the ongoing alerts about Mednax for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Mednax Inc help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Mednax Inc had very high historical volatility over the last 90 days
The company generated the yearly revenue of 2.01 B. Annual Net Loss to common stockholders was (99.07 M) with gross profit of 496.24 M.
Evaluating Mednax's performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate Mednax's stock performance include:
  • Analyzing Mednax's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
  • Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Mednax's stock is overvalued or undervalued compared to its peers.
  • Examining Mednax's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
  • Evaluating Mednax's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Mednax's management team can help you assess the Company's leadership.
  • Pay attention to analyst opinions and ratings of Mednax's stock. These opinions can provide insight into Mednax's potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating Mednax's stock performance is not an exact science, and many factors can impact Mednax's stock market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.

Complementary Tools for Mednax Stock analysis

When running Mednax's price analysis, check to measure Mednax's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Mednax is operating at the current time. Most of Mednax's value examination focuses on studying past and present price action to predict the probability of Mednax's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Mednax's price. Additionally, you may evaluate how the addition of Mednax to your portfolios can decrease your overall portfolio volatility.
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments